Efficacy and Safety of Sarilumab in Combination with Csdmards in Patients with Active Rheumatoid Arthritis Who Were Inadequate Responders or Intolerant of Anti-TNF-I± Therapy: Results from a Phase 3 Study

被引：0

作者：

Fleischmann, Roy ^{[1
]}

Castelar-Pinheiro, Geraldo ^{[2
]}

Brzezicki, Jan ^{[3
]}

Hrycaj, Pawel ^{[4
]}

Lin, Yong ^{[5
]}

van adelsberg, Janet ^{[6
]}

Graham, Neil ^{[7
]}

van Hoogstraten, Hubert ^{[5
]}

Bauer, Deborah ^{[5
]}

Burmester, Gerd ^{[8
]}

机构：

[1] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA

[2] Univ Estado Rio de Janeiro, Discipline Rheumatol, BR-20550011 Rio De Janeiro, Brazil

[3] Ctr Klin Badawcze, Elblag, Poland

[4] Poznan Univ Med Sci, Poznan, Poland

[5] Sanofi, Bridgewater, NJ USA

[6] Regeneron Pharmaceut Inc, Clin Sci, Tarrytown, NY 10591 USA

[7] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA

[8] Charite, Dept Rheumatol & Clin Immunol, D-13353 Berlin, Germany

来源：

ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

970

引用

页数：2

共 50 条

[1] EFFICACY AND SAFETY OF SARILUMAB IN COMBINATION WITH CSDMARDS IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS WHO WERE INADEQUATE RESPONDERS OR INTOLERANT OF ANTI-TNF-α THERAPY: RESULTS FROM A PHASE 3 STUDY
Fleischmann, Roy
Pinheiro Geraldo Da, R. C.
Anie Brzezicki, J.
Hrycaj, Pawel
Lin, Yong
Van Adelsberg, Janet
Graham, Neil
Van Hoogstraten, Hubert
Bauer, Deborah
Burmester Gerd, R.
INTERNAL MEDICINE JOURNAL, 2016, 46 : 41 - 41
[2] Impact of Sarilumab on Fatigue, Pain, Morning Stiffness, Productivity, and Health Related Quality of Life (HRQoL) in Patients with Active Rheumatoid Arthritis Who Were Inadequate Responders or Intolerant of Anti-TNF-(I)over-cap± Therapy: Results from a Phase 3 Study (RCT)
Strand, Vibeke
Kosinski, Mark
Graham, Neil
Chen, Chieh-I
Joseph, George J.
Bauer, Deborah
Lin, Yong
Pacheco-Tena, Cesar
Fleischmann, Roy
ARTHRITIS & RHEUMATOLOGY, 2015, 67
[3] Immunogenicity of Sarilumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Inadequate Responders or Intolerant to Disease-Modifying Antirheumatic Drugs
Alvin F. Wells
Janie Parrino
Erin K. Mangan
Anne Paccaly
Yong Lin
Christine Xu
Chunpeng Fan
Neil M. H. Graham
Hubert van Hoogstraten
Albert Torri
Rheumatology and Therapy, 2019, 6 : 339 - 352
[4] Immunogenicity of Sarilumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Inadequate Responders or Intolerant to Disease-Modifying Antirheumatic Drugs
Wells, Alvin F.
Parrino, Janie
Mangan, Erin K.
Paccaly, Anne
Lin, Yong
Xu, Christine
Fan, Chunpeng
Graham, Neil M. H.
van Hoogstraten, Hubert
Torri, Albert
RHEUMATOLOGY AND THERAPY, 2019, 6 (03) : 339 - 352
[5] Sustained Response in a Phase 3 Study of Sarilumab Plus Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients with Active, Efficacy of Sarilumab in Combination with Csdmards in Patients with Rheumatoid Arthritis and Inadequate Response to TNF Inhibitors By Baseline Levels of Disease Activity
Fleischmann, Roy
van Hoogstraten, Hubert
Jayawardena, Shyamalie
Mangan, Erin K.
Ching, Daniel
Burmester, Gerd R.
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[6] The efficacy and safety of abatacept in patients with active rheumatoid arthritis and an inadequate response to anti-TNF therapy: Results from the arrive trial
Emery, P.
Pritchard, C.
Zhou, X.
Genovese, M.
Schiff, M.
RHEUMATOLOGY, 2008, 47 : II45 - II45
[7] Efficacy of Sarilumab Plus csDMARDs in Rheumatoid Arthritis Patients who had an Inadequate Response to One or More than One Prior TNF Inhibitor
Genovese, Mark
Pinheiro, Geraldo
Mangan, Erin
Lin, Yong
van Adelsberg, Janet
van Hoogstraten, Hubert
Kimura, Toshio
Fleischmann, Roy
Fiore, Stefano
JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 896 - 896
[8] EFFICACY OF SARILUMAB PLUS CSDMARDS IN RHEUMATOID ARTHRITIS PATIENTS WHO HAD AN INADEQUATE RESPONSE TO ONE OR MORE THAN ONE PRIOR TNF INHIBITOR
Genovese, M.
Pinheiro, G.
Mangan, E.
Lin, Y.
Van Hoogstraten, H.
Fleischmann, R.
INTERNAL MEDICINE JOURNAL, 2017, 47 : 29 - 29
[9] EFFICACY OF SARILUMAB PLUS CSDMARDS IN RHEUMATOID ARTHRITIS PATIENTS WHO HAD AN INADEQUATE RESPONSE TO ONE OR MORE THAN ONE PRIOR TNF INHIBITOR
Genovese, M. C.
Pinheiro, G. da R. C.
Mangan, E. K.
Lin, Y.
van Adelsberg, J.
van Hoogstraten, H.
Thompson, D.
Fleischmann, R.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 730 - 731
[10] LONG-TERM EFFICACY WITH 5-YEAR-RADIOGRAPHIC RESULTS AND SAFETY OF SARILUMAB IN COMBINATION WITH CSDMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS
Burmester, G. R.
Lin, Y.
St John, G.
Wang, S.
Gomez-Reino, J. J.
Maldonado-Cocco, J. A.
Salazar, J. C.
van der Heijde, D.
Genovese, M. C.
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 946 - 947

← 1 2 3 4 5 →